Europe Minor Cannabinoids Market Databank

Europe Minor Cannabinoids Market Databank

The Minor Cannabinoids market was valued at $7,230.0 Million in 2020, and is projected to reach $13,813.2 Million by 2029 growing at a CAGR of 7.51% from 2021 to 2029. Cannabigerol (CBG) segment is expected to be the highest contributor to this market, with $2,174.2 Million in 2020, and is anticipated to reach $4,198.5 Million by 2029, registering a CAGR of 7.64%. Cannabigerolic acid (CBGA) segment is anticipated to reach $1,080.2 Million by 2029 with the highest CAGR of 7.70%. Cannabigerol (CBG) and Cannabichromene (CBC) segments collectively expected to account for about 56.6% share of the Minor Cannabinoids market in 2020, with the former constituting around 30.1% share. Cannabigerolic acid (CBGA) and Cannabigerol (CBG) segments are expected to witness significant growth rates at a CAGR of 7.70% and 7.64% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 37.8% in the overall Minor Cannabinoids market in 2020, and is anticipated to reach 38.2% by 2029.

The report provides market intelligence on various market segments and geography, including market size and forecast information. Its primary goals are to deliver a thorough global market intelligence report by providing detailed segmentation, growth rates, market dynamics, industry structure and developments, market situation, and trends. To determine the market size and forecast, we conducted extensive secondary research to gain a comprehensive understanding of the market in each region. In addition, we carried out extensive primary research by conducting interviews with key executives in the industry. These interviews helped us to fill any data gaps identified during the secondary research. We used various secondary sources such as encyclopedias, directories, and databases to gather relevant information for this extensive techno-commercial study. We interviewed selected experts from manufacturers and suppliers to obtain and verify critical information, as well as to assess future prospects. The research team evaluated the reliability of the obtained information before using it. In some cases, a combination of multiple sources was used. Sprout Intelligence conducted an in-depth analysis of the market segmentation, which is a crucial component of our market intelligence reports.


1. GLOBAL MINOR CANNABINOIDS MARKET, BY PRODUCT
1.1. OVERVIEW
1.2. CANNABIGEROL (CBG)
1.2.1 CANNABIGEROL (CBG) MARKET, BY REGION
1.2.1.1 North America Cannabigerol (CBG) Market, By Country
1.2.1.2 Europe Cannabigerol (CBG) Market, By Country
1.2.1.3 Asia-Pacific Cannabigerol (CBG) Market, By Country
1.2.1.4 Rest of World Cannabigerol (CBG) Market, By Country
1.3. CANNABICHROMENE (CBC)
1.3.1 CANNABICHROMENE (CBC) MARKET, BY REGION
1.3.1.1 North America Cannabichromene (CBC) Market, By Country
1.3.1.2 Europe Cannabichromene (CBC) Market, By Country
1.3.1.3 Asia-Pacific Cannabichromene (CBC) Market, By Country
1.3.1.4 Rest of World Cannabichromene (CBC) Market, By Country
1.4. CANNABINOL (CBN)
1.4.1 CANNABINOL (CBN) MARKET, BY REGION
1.4.1.1 North America Cannabinol (CBN) Market, By Country
1.4.1.2 Europe Cannabinol (CBN) Market, By Country
1.4.1.3 Asia-Pacific Cannabinol (CBN) Market, By Country
1.4.1.4 Rest of World Cannabinol (CBN) Market, By Country
1.5. TETRAHYDROCANNABIVARIN (THCV)
1.5.1 TETRAHYDROCANNABIVARIN (THCV) MARKET, BY REGION
1.5.1.1 North America Tetrahydrocannabivarin (THCV) Market, By Country
1.5.1.2 Europe Tetrahydrocannabivarin (THCV) Market, By Country
1.5.1.3 Asia-Pacific Tetrahydrocannabivarin (THCV) Market, By Country
1.5.1.4 Rest of World Tetrahydrocannabivarin (THCV) Market, By Country
1.6. CANNABIGEROLIC ACID (CBGA)
1.6.1 CANNABIGEROLIC ACID (CBGA) MARKET, BY REGION
1.6.1.1 North America Cannabigerolic acid (CBGA) Market, By Country
1.6.1.2 Europe Cannabigerolic acid (CBGA) Market, By Country
1.6.1.3 Asia-Pacific Cannabigerolic acid (CBGA) Market, By Country
1.6.1.4 Rest of World Cannabigerolic acid (CBGA) Market, By Country
1.7. OTHER PRODUCTS
1.7.1 OTHER PRODUCTS MARKET, BY REGION
1.7.1.1 North America Other Products Market, By Country
1.7.1.2 Europe Other Products Market, By Country
1.7.1.3 Asia-Pacific Other Products Market, By Country
1.7.1.4 Rest of World Other Products Market, By Country
2. GLOBAL MINOR CANNABINOIDS MARKET, BY APPLICATION
2.1. OVERVIEW
2.2. INFLAMMATION
2.2.1 INFLAMMATION MARKET, BY REGION
2.2.1.1 North America Inflammation Market, By Country
2.2.1.2 Europe Inflammation Market, By Country
2.2.1.3 Asia-Pacific Inflammation Market, By Country
2.2.1.4 Rest of World Inflammation Market, By Country
2.3. PAIN MANAGEMENT
2.3.1 PAIN MANAGEMENT MARKET, BY REGION
2.3.1.1 North America Pain Management Market, By Country
2.3.1.2 Europe Pain Management Market, By Country
2.3.1.3 Asia-Pacific Pain Management Market, By Country
2.3.1.4 Rest of World Pain Management Market, By Country
2.4. NEUROLOGICAL DISORDERS
2.4.1 NEUROLOGICAL DISORDERS MARKET, BY REGION
2.4.1.1 North America Neurological Disorders Market, By Country
2.4.1.2 Europe Neurological Disorders Market, By Country
2.4.1.3 Asia-Pacific Neurological Disorders Market, By Country
2.4.1.4 Rest of World Neurological Disorders Market, By Country
2.5. CANCER
2.5.1 CANCER MARKET, BY REGION
2.5.1.1 North America Cancer Market, By Country
2.5.1.2 Europe Cancer Market, By Country
2.5.1.3 Asia-Pacific Cancer Market, By Country
2.5.1.4 Rest of World Cancer Market, By Country
2.6. OTHER APPLICATIONS
2.6.1 OTHER APPLICATIONS MARKET, BY REGION
2.6.1.1 North America Other Applications Market, By Country
2.6.1.2 Europe Other Applications Market, By Country
2.6.1.3 Asia-Pacific Other Applications Market, By Country
2.6.1.4 Rest of World Other Applications Market, By Country
3. GLOBAL MINOR CANNABINOIDS MARKET, BY REGION
3.1. OVERVIEW
3.2. EUROPE
3.2.1 EUROPE MINOR CANNABINOIDS MARKET, BY PRODUCT
3.2.2 EUROPE MINOR CANNABINOIDS MARKET, BY APPLICATION
3.2.3 EUROPE MINOR CANNABINOIDS MARKET, BY COUNTRY
3.2.3.1 Germany
3.2.3.1.1 Germany Minor Cannabinoids Market, By Product
3.2.3.1.2 Germany Minor Cannabinoids Market, By Application
3.2.3.2 France
3.2.3.2.1 France Minor Cannabinoids Market, By Product
3.2.3.2.2 France Minor Cannabinoids Market, By Application
3.2.3.3 UK
3.2.3.3.1 UK Minor Cannabinoids Market, By Product
3.2.3.3.2 UK Minor Cannabinoids Market, By Application
3.2.3.4 Italy
3.2.3.4.1 Italy Minor Cannabinoids Market, By Product
3.2.3.4.2 Italy Minor Cannabinoids Market, By Application
3.2.3.5 Spain
3.2.3.5.1 Spain Minor Cannabinoids Market, By Product
3.2.3.5.2 Spain Minor Cannabinoids Market, By Application
3.2.3.6 Rest of Europe
3.2.3.6.1 Rest of Europe Minor Cannabinoids Market, By Product
3.2.3.6.2 Rest of Europe Minor Cannabinoids Market, By Application

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings